[1] 田田,赵殿儒,贾媛媛,等.瑞舒伐他汀联合尼可地尔治疗急性冠状动脉综合征临床效果[J].解放军医药杂志,2021,33(1):49-53.
[2] 王悦,刘倍倍,陈蕾蕾,等.急性冠状动脉综合征患者替格瑞洛治疗后残余血小板高反应性的影响因素研究[J].中国医药,2021,16(2):161-165.
[3] 穆利英,吴昱,孟帅,等.纤维蛋白原与急性冠脉综合征患者冠状动脉病变严重程度的关系研究[J].实用心脑肺血管病杂志,2020,28(2):23-26.
[4] 葛均波,徐永健.内科学[M].8 版.北京:人民卫生出版社,2013:111-115.
[5] Kang SJ,Mintz GS,Park DW,et al.Mechanisms of in - stent restenosis after drug-eluting stent implantation intravascular ultrasound analysis[J].Circ Cardiovasc Interv,2011,4(1):9.
[6] Morrow DA,Scirica BM,Karwatowska-Prokopczuk E,et al.Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes:the MERLIN-TIMI 36 randomized trial[J].JAMA,2007,297(16):1775-1783.
[7] 刘晓,陆红. PTCA 术后再狭窄形成机制的研究进展[J].中国心血管病研究,2007,11(5):854-856.
[8] Ninio E.Platelet activating factor acetylhydrolase activity indicates angiographic coronary arterv disease independently of systemic inflammation and other risk factors:the Ludwigshafen Risk and Cardiovascular Health Study[J].Circulation,2005,112(8):108-109. |
| [1] |
Wei Lisha. Effects of Clopidogrel Combined With Aspirin on Cerebral Hemodynamics and Cytokines in Patients With Transient Ischemic Attack[J]. journal1, 2022, 42(2): 5-7. |
| [2] |
. [J]. journal1, 2022, 42(2): 123-125. |
| [3] |
. [J]. journal1, 2022, 42(1): 72-73. |
| [4] |
. [J]. journal1, 2021, 41(6): 57-58. |
| [5] |
. [J]. journal1, 2021, 41(5): 95-95. |
| [6] |
. [J]. journal1, 2021, 41(4): 49-50. |
|
|
|
2022, Vol. 42 
